Literature DB >> 3487782

Membrane-dependent coagulation reaction is independent of the concentration of phospholipid-bound substrate: fluid phase factor X regulates the extrinsic system.

S D Forman, Y Nemerson.   

Abstract

Negatively charged phospholipids accelerate blood coagulation; one suggestion is that the binding of the gamma-carboxyglutamic acid-containing zymogens to these lipid surfaces increases their effective concentration as substrates. Alternatively, the charged phospholipids could enhance the direct interaction of substrate with the catalytic complex, which is localized at the membrane surface. We distinguished the alternatives by using prothrombin fragment 1 to compete with the substrate for membrane binding sites without interfering with the direct enzyme-substrate interaction. In a tissue factor-factor VIIa system containing neutral phospholipids (to which the substrate does not bind), prothrombin fragment 1 had no significant effect on factor X activation (Km, 877 +/- 111 nM and 791 +/- 103 nM, with and without prothrombin fragment 1, respectively). In contrast, in a system containing 30% phosphatidylserine, prothrombin fragment 1 displaced phospholipid-bound factor X, increasing the free factor X concentration and the reaction velocity in all 22 determinations. As the velocity increases correlated only with the free factor X concentration, we conclude that the free factor X concentration controls this reaction velocity. The Km in the 30% phosphatidylserine system, calculated using free factor X concentration, was 41 +/- 5 nM and 63 +/- 9 nM, with and without prothrombin fragment 1, respectively. Thus, the negatively charged lipids decreased the intrinsic Km by over 90%. The methodology employed should be applicable to ligand-receptor systems in which ligand binds nonspecifically to the membrane surface.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3487782      PMCID: PMC323804          DOI: 10.1073/pnas.83.13.4675

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  The activation of coagulation factor X. Identity of cleavage sites in the alternative activation pathways and characterization of the COOH-terminal peptide.

Authors:  J Jesty; A K Spencer; Y Nakashima; Y Nemerson; W Konigsberg
Journal:  J Biol Chem       Date:  1975-06-25       Impact factor: 5.157

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Monoclonal antibodies against bovine tissue factor, which block interaction with factor VIIa.

Authors:  S D Carson; R Bach; S M Carson
Journal:  Blood       Date:  1985-07       Impact factor: 22.113

4.  Studies on the formation of the prothrombin-converting complex.

Authors:  F Jobin; M P Esnouf
Journal:  Biochem J       Date:  1967-03       Impact factor: 3.857

5.  Phospholipid-binding properties of bovine factor V and factor Va.

Authors:  J W Bloom; M E Nesheim; K G Mann
Journal:  Biochemistry       Date:  1979-10-02       Impact factor: 3.162

6.  The conversion of prothrombin to thrombin. I. Characterization of the reaction products formed during the activation of bovine prothrombin.

Authors:  W G Owen; C T Esmon; C M Jackson
Journal:  J Biol Chem       Date:  1974-01-25       Impact factor: 5.157

7.  "Clotspeed," a mathematical simulation of the functional properties of prothrombinase.

Authors:  M E Nesheim; R P Tracy; K G Mann
Journal:  J Biol Chem       Date:  1984-02-10       Impact factor: 5.157

8.  Immunoaffinity purification of bovine factor VII.

Authors:  R Bach; J Oberdick; Y Nemerson
Journal:  Blood       Date:  1984-02       Impact factor: 22.113

9.  The role of phospholipids and factor Va in the prothrombinase complex.

Authors:  J Rosing; G Tans; J W Govers-Riemslag; R F Zwaal; H C Hemker
Journal:  J Biol Chem       Date:  1980-01-10       Impact factor: 5.157

10.  Kinetic studies of prothrombin activation: effect of factor Va and phospholipids on the formation of the enzyme-substrate complex.

Authors:  J L van Rijn; J W Govers-Riemslag; R F Zwaal; J Rosing
Journal:  Biochemistry       Date:  1984-09-25       Impact factor: 3.162

View more
  8 in total

1.  Diffusion and reaction in the cell glycocalyx and the extracellular matrix.

Authors:  Howard A Levine; Maria P McGee; Susana Serna
Journal:  J Math Biol       Date:  2009-03-10       Impact factor: 2.259

Review 2.  Tissue factor encryption and decryption: facts and controversies.

Authors:  L Vijaya Mohan Rao; Hema Kothari; Usha R Pendurthi
Journal:  Thromb Res       Date:  2012-03-06       Impact factor: 3.944

3.  Surface-mediated enzymatic reactions: simulations of tissue factor activation of factor X on a lipid surface.

Authors:  R Gentry; L Ye; Y Nemerson
Journal:  Biophys J       Date:  1995-08       Impact factor: 4.033

Review 4.  Tissue factor/factor VIIa complex: role of the membrane surface.

Authors:  James H Morrissey; Emad Tajkhorshid; Stephen G Sligar; Chad M Rienstra
Journal:  Thromb Res       Date:  2012-03-12       Impact factor: 3.944

Review 5.  Blood clotting reactions on nanoscale phospholipid bilayers.

Authors:  James H Morrissey; Vincent Pureza; Rebecca L Davis-Harrison; Stephen G Sligar; Y Zenmei Ohkubo; Emad Tajkhorshid
Journal:  Thromb Res       Date:  2008       Impact factor: 3.944

Review 6.  Regulation of tissue factor coagulant activity on cell surfaces.

Authors:  L V M Rao; U R Pendurthi
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824

Review 7.  Protein-membrane interactions: blood clotting on nanoscale bilayers.

Authors:  J H Morrissey; V Pureza; R L Davis-Harrison; S G Sligar; C M Rienstra; A Z Kijac; Y Z Ohkubo; E Tajkhorshid
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

8.  The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII.

Authors:  V J Bom; R M Bertina
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.